Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Göran Walldius

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|July 28, 2011
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammationMieke Van Hemelrijck, Ingmar Jungner, Göran Walldius, et al.
Cancer Causes & Control : CCC|May 13, 2011
Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Göran Walldius, Ingmar Jungner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2020
Association of Serum Immunoglobulin Levels with Solid Cancer: A Systematic Review and Meta-analysisIoannis Peppas, Gincy George, Sam Sollie, et al.
Cancer Causes & Control : CCC|June 20, 2012
Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Ruben Hermans, Karl Michaelsson, et al.
British Journal of Sports Medicine|July 19, 2020
A Swedish primary healthcare prevention programme focusing on promotion of physical activity and a healthy lifestyle reduced cardiovascular events and mortality: 22-year follow-up of 5761 study participants and a reference groupGunilla Journath, Niklas Hammar, Max Vikström, et al.
BMC Molecular and Cell Biology|July 25, 2019
Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysisAida Santaolalla, Hans Garmo, Anita Grigoriadis, et al.
British Journal of Cancer|April 5, 2017
Serum inflammatory markers and colorectal cancer risk and survivalSundeep Ghuman, Mieke Van Hemelrijck, Hans Garmo, et al.
Plos One|August 24, 2018
Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels - The AMORIS studyTorbjörn Ivert, Håkan Malmström, Niklas Hammar, et al.
British Journal of Cancer|October 16, 2015
Serum lactate dehydrogenase and survival following cancer diagnosisWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
Oncotarget|April 19, 2017
Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS StudyAndrew Yiu, Mieke Van Hemelrijck, Hans Garmo, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|July 28, 2011
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammationMieke Van Hemelrijck, Ingmar Jungner, Göran Walldius, et al.
Cancer Causes & Control : CCC|May 13, 2011
Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Göran Walldius, Ingmar Jungner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2020
Association of Serum Immunoglobulin Levels with Solid Cancer: A Systematic Review and Meta-analysisIoannis Peppas, Gincy George, Sam Sollie, et al.
Cancer Causes & Control : CCC|June 20, 2012
Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Ruben Hermans, Karl Michaelsson, et al.
British Journal of Sports Medicine|July 19, 2020
A Swedish primary healthcare prevention programme focusing on promotion of physical activity and a healthy lifestyle reduced cardiovascular events and mortality: 22-year follow-up of 5761 study participants and a reference groupGunilla Journath, Niklas Hammar, Max Vikström, et al.
BMC Molecular and Cell Biology|July 25, 2019
Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysisAida Santaolalla, Hans Garmo, Anita Grigoriadis, et al.
British Journal of Cancer|April 5, 2017
Serum inflammatory markers and colorectal cancer risk and survivalSundeep Ghuman, Mieke Van Hemelrijck, Hans Garmo, et al.
Plos One|August 24, 2018
Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels - The AMORIS studyTorbjörn Ivert, Håkan Malmström, Niklas Hammar, et al.
British Journal of Cancer|October 16, 2015
Serum lactate dehydrogenase and survival following cancer diagnosisWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
Oncotarget|April 19, 2017
Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS StudyAndrew Yiu, Mieke Van Hemelrijck, Hans Garmo, et al.
Pageof 8